Roger Meier

Roger Meier is an experienced biotechnology and pharmaceutical leader with a diverse background in founding and advising companies. Currently serving as a Senior Strategic Advisor at PharmaX Solutions, Roger has held several significant leadership roles including Chairman of the Board and Co-Founder at Aurealis Therapeutics and Acthera Therapeutics Ltd. Roger is also the Chairman of the Board at NEMIS Technologies AG and a Co-Founder of Versameb AG and Elthera AG. In addition, Roger has been a foundational figure at Clarena AG since 1998 and has provided advisory support to Cellestia Biotech. Notably, Roger co-founded T3 Pharmaceuticals AG, which was sold to Boehringer-Ingelheim in 2023. Roger Meier has academic credentials from the University of Applied Sciences Basel.